Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,401,000 | 681,000 | 2,261,000 | 2,266,000 | 1,499,000 |
| Depreciation Amortization | 311,000 | 156,000 | 1,549,000 | 457,000 | 299,000 |
| Income taxes - deferred | -15,000 | -18,000 | -109,000 | 8,000 | -17,000 |
| Accounts receivable | -274,000 | -215,000 | -16,000 | -180,000 | -152,000 |
| Other Working Capital | -265,000 | -277,000 | 284,000 | -163,000 | -404,000 |
| Other Operating Activity | 584,000 | 420,000 | 229,000 | 357,000 | 259,000 |
| Operating Cash Flow | $1,742,000 | $747,000 | $4,198,000 | $2,745,000 | $1,484,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,000 | 24,000 | 54,000 | -29,000 | -34,000 |
| PPE Investments | -266,000 | -138,000 | -564,000 | -387,000 | -232,000 |
| Net Acquisitions | N/A | N/A | -293,000 | -293,000 | -293,000 |
| Other Investing Activity | -4,000 | -8,000 | -14,000 | -5,000 | -1,000 |
| Investing Cash Flow | $-244,000 | $-122,000 | $-817,000 | $-714,000 | $-560,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,053,000 | 1,138,000 | -989,000 | 139,000 | -30,000 |
| Debt Issued | 0 | N/A | 1,188,000 | 497,000 | 497,000 |
| Debt Repayment | -1,086,000 | -1,082,000 | -655,000 | -655,000 | -139,000 |
| Common Stock Issued | 138,000 | 127,000 | 101,000 | 83,000 | 65,000 |
| Common Stock Repurchased | -597,000 | -306,000 | -1,210,000 | -804,000 | -516,000 |
| Dividend Paid | -879,000 | -417,000 | -1,823,000 | -1,300,000 | -880,000 |
| Other Financing Activity | -43,000 | -23,000 | 132,000 | 145,000 | 136,000 |
| Financing Cash Flow | $-1,414,000 | $-563,000 | $-3,256,000 | $-1,895,000 | $-867,000 |
| Exchange Rate Effect | -2,000 | -15,000 | 67,000 | 47,000 | 62,000 |
| Beginning Cash Position | 1,288,000 | 1,288,000 | 1,096,000 | 1,096,000 | 1,096,000 |
| End Cash Position | 1,370,000 | 1,335,000 | 1,288,000 | 1,279,000 | 1,215,000 |
| Net Cash Flow | $82,000 | $47,000 | $192,000 | $183,000 | $119,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,742,000 | 747,000 | 4,198,000 | 2,745,000 | 1,484,000 |
| Capital Expenditure | -266,000 | -138,000 | -564,000 | -387,000 | -232,000 |
| Free Cash Flow | 1,476,000 | 609,000 | 3,634,000 | 2,358,000 | 1,252,000 |